Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study

We assessed if delisting of OxyContin was associated with changes in the use of unregulated opioids and other substances among people who use opioids (PWUO).

Original research | 2022
Policy/Regulatory, Outcomes, Illegal drugs, About PWUD

Much being Written about Us, not much being Written with Us: Examining how alcohol and other drug use by indigenous Australians is portrayed in Australian Government policies and strategies: A discourse analysis

Using critical discourse analysis, this study examined the portrayal of Aboriginal and Torres Strait Islander people in Australian Government policies regarding alcohol and other drug (AOD) use.

Original research | 2022
Indigenous, Policy/Regulatory

Increases in Methamphetamine Injection among Treatment Admissions in the U.S

Prior research indicates rising methamphetamine use and harms in the U.S., potentially related to increases in methamphetamine injection.

Original research | 2022
Stimulants, Injecting drugs, About PWUD

Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario

London InterCommunity Health Centre (LIHC) launched a safer opioid supply (SOS) program in 2016, where clients are prescribed pharmaceutical opioids and provided with comprehensive health and socia

Original research | 2022
Evidence base, Safer supply, Outcomes, Wrap-around services, About PWUD, Transitions in care/treatment, Hospitals, Advocacy

The association of chronic pain and opioid withdrawal in men and women with opioid use disorder

The goal of this study was to examine the roles of chronic pain and gender on opioid withdrawal severity using a large, multi-site database.

Original research | 2022
Withdrawal, Sex/Gender , Chronic pain, Transitions in care/treatment, About PWUD

Illicit Drug Toxicity Type of Drug Data - Data to July 31, 2022

Report | 2022
Overdose, Mortality, About PWUD, Illegal drugs, Drug checking

MOUD saves lives, especially after 60 days, and the longer the better

Commentary | 2022
Overdose, Mortality, Substitution/OAT, About PWUD

Social service providers’ perspectives on caring for structurally vulnerable hospital patients who use drugs: a qualitative study

Our objectives were to: 1) explore social service providers’ perspectives on addressing social needs for this patient population; and 2) identify what possible strategies social service providers s

Original research | 2022
Social services, Barriers and enablers, Housing, Hospitals

Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review

This integrative review of the literature was conducted to explore the facilitators and barriers of OAT in rural and remote Canadian communities.

Lit review | 2022
Rural/remote, Barriers and enablers, About prescribers, About PWUD, Substitution/OAT

Patient perspectives on depot buprenorphine treatment for opioid addiction – a qualitative interview study

The purpose of this study was to explore patients’ experiences of depot injections and their reasons for continuing, discontinuing, or declining depot injection treatment.

Original research | 2022
Substitution/OAT, About PWUD, Barriers and enablers

The Opioid Crisis: The War on Drugs Is Over. Long Live the War on Drugs

Commentary | 2023
Policy/Regulatory, Equity, Legal system/law enforcement

Marked Increase in Amphetamine-Related Emergency Department Visits and Inpatient Admissions in Toronto, Canada, 2014–2021

We report emergency department and inpatient amphetamine-related trends focusing on co-occurring substance use and psychiatric diagnoses at the Centre for Addiction and Mental Health, the largest m

Original research | 2022
Stimulants, Hospitals, Mental health

Questions et réponse pour les pharmacies : Politique de remboursement pour les traitements de maintien à la méthadone (TMM) du Programme de médicaments de l’Ontario

Politique | 2022
à propos des pharmaciens, la politique / le cadre de réglementation, le traitement de substitution/TAO

Questions and Answers for Pharmacies: Policy for Methadone Maintenance Treatment (MMT) Reimbursement under the Ontario Drug Benefit Program

Policy | 2022
About pharmacists, Policy/Regulatory, Substitution/OAT

Stratégie nationale 2022-2025 de prévention des surdoses de substances psychoactives

Politique | 2022
la surdose, la politique / le cadre de réglementation

Knowing how to recognize and respond to a severe intoxication or overdose related to psychoactive substance use or alcohol withdrawal – A toolkit

Guide or handbook | 2022
Workplace, Overdose, Harm reduction, Wrap-around services

Savoir reconnaître et agir lors d’une intoxication sévère ou d’une surdose liée à la consommation de substances psychoactives ou d’un sevrage d’alcool – Boîte à outils

Manuel | 2022
le lieu de travail, la surdose, la réduction des méfaits, les services enveloppants

Expérience des fournisseurs de services de réduction des méfaits lors de la double urgence de santé publique au Canada

Rapport | 2022
la réduction des méfaits, les services enveloppants, les services sociaux, le lieu de travail, la santé mentale

Experiences of Harm Reduction Service Providers During Dual Public Health Emergencies in Canada

Report | 2022
Harm reduction, Wrap-around services, Social services, Workplace, Mental health

State prescribing cap laws’ association with opioid analgesic prescribing and opioid overdose

This study assessed the effects of state prescribing cap laws that limit the dose and/or duration of dispensed opioid prescriptions on opioid prescribing patterns and opioid overdose.

Original research | 2022
About prescribers, Overdose, Policy/Regulatory, Outcomes

Refine Your Search

Keywords
Format
Region